Video

Dr. Chagpar on Management of the Axilla in Breast Cancer

Anees B. Chagpar, MD, FACS, associate professor, Department of Surgery, Yale School of Medicine, assistant director, Global Oncology, Yale Comprehensive Cancer Center, discusses the management of the axilla in breast cancer.

Anees B. Chagpar, MD, FACS, associate professor, Department of Surgery, Yale School of Medicine, assistant director, Global Oncology, Yale Comprehensive Cancer Center, discusses the management of the axilla in breast cancer.

Neoadjuvant chemotherapy is becoming a mainstay in the treatment of patients with locally advanced and operable breast cancer, says Chagpar. This has prompted many physicians to question how to best manage the axilla. Robust clinical trial data have since shown that a sentinel lymph node biopsy is feasible and accurate in the setting of neoadjuvant chemotherapy.

Therefore, for many patients who have had a fine needle aspiration biopsy or a core needle biopsy that indicates lymph node metastases prior to neoadjuvant chemotherapy, patients no longer have to undergo an axillary node dissection, says Chagpar. Rather, a sentinel node biopsy can be done to assess where the patient stands at that point. If they have residual disease, they can then opt for an axillary node dissection. Moreover, there are now trials looking at radiation therapy alone for those patients, concludes Chagpar.

Related Videos
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Alastair Thompson, BSc, MBChB, MD, FRCS
C. Ola Landgren, MD, PhD
Sara M. Tolaney, MD, MPH
Adam M. Brufsky, MD, PhD, FACP
Justin M. Watts, MD
Sara M. Tolaney, MD, MPH
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine